BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26527286)

  • 1. A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.
    Walsh KM; de Smith AJ; Hansen HM; Smirnov IV; Gonseth S; Endicott AA; Xiao J; Rice T; Fu CH; McCoy LS; Lachance DH; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR; Ma X; Metayer C; Wiemels JL
    Cancer Res; 2015 Nov; 75(22):4884-94. PubMed ID: 26527286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
    Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
    Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
    Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
    Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
    BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
    Sherborne AL; Hosking FJ; Prasad RB; Kumar R; Koehler R; Vijayakrishnan J; Papaemmanuil E; Bartram CR; Stanulla M; Schrappe M; Gast A; Dobbins SE; Ma Y; Sheridan E; Taylor M; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Moorman AV; Harrison CJ; Tomlinson IP; Richards S; Zimmermann M; Szalai C; Semsei AF; Erdelyi DJ; Krajinovic M; Sinnett D; Healy J; Gonzalez Neira A; Kawamata N; Ogawa S; Koeffler HP; Hemminki K; Greaves M; Houlston RS
    Nat Genet; 2010 Jun; 42(6):492-4. PubMed ID: 20453839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia.
    Zhou X; Liao F; Zhang J; Qin Y; Xu H; Ding Z; Zhang Y; Zhang F
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.
    Vijayakrishnan J; Kumar R; Henrion MY; Moorman AV; Rachakonda PS; Hosen I; da Silva Filho MI; Holroyd A; Dobbins SE; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Heilmann-Heimbach S; Jöckel KH; Greaves M; Harrison CJ; Bartram CR; Schrappe M; Stanulla M; Hemminki K; Houlston RS
    Leukemia; 2017 Mar; 31(3):573-579. PubMed ID: 27694927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia.
    de Smith AJ; Walsh KM; Francis SS; Zhang C; Hansen HM; Smirnov I; Morimoto L; Whitehead TP; Kang A; Shao X; Barcellos LF; McKean-Cowdin R; Zhang L; Fu C; Wang R; Yu H; Hoh J; Dewan AT; Metayer C; Ma X; Wiemels JL
    Int J Cancer; 2018 Dec; 143(11):2647-2658. PubMed ID: 29923177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
    Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
    Xu H; Zhang H; Yang W; Yadav R; Morrison AC; Qian M; Devidas M; Liu Y; Perez-Andreu V; Zhao X; Gastier-Foster JM; Lupo PJ; Neale G; Raetz E; Larsen E; Bowman WP; Carroll WL; Winick N; Williams R; Hansen T; Holm JC; Mardis E; Fulton R; Pui CH; Zhang J; Mullighan CG; Evans WE; Hunger SP; Gupta R; Schmiegelow K; Loh ML; Relling MV; Yang JJ
    Nat Commun; 2015 Jun; 6():7553. PubMed ID: 26104880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population.
    Bahari G; Hashemi M; Naderi M; Taheri M
    Tumour Biol; 2016 Jul; 37(7):9579-86. PubMed ID: 26790447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
    Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.
    Archer NP; Perez-Andreu V; Scheurer ME; Rabin KR; Peckham-Gregory EC; Plon SE; Zabriskie RC; De Alarcon PA; Fernandez KS; Najera CR; Yang JJ; Antillon-Klussmann F; Lupo PJ
    Cancer; 2016 Dec; 122(23):3697-3704. PubMed ID: 27529658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia.
    Walsh KM; de Smith AJ; Welch TC; Smirnov I; Cunningham MJ; Ma X; Chokkalingam AP; Dahl GV; Roberts W; Barcellos LF; Buffler PA; Metayer C; Wiemels JL
    Am J Hematol; 2014 Jul; 89(7):721-5. PubMed ID: 24753091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
    Bhandari P; Ahmad F; Mandava S; Das BR
    Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants.
    Singh SK; Lupo PJ; Scheurer ME; Saxena A; Kennedy AE; Ibrahimou B; Barbieri MA; Mills KI; McCauley JL; Okcu MF; Dorak MT
    Medicine (Baltimore); 2016 Nov; 95(46):e5300. PubMed ID: 27861356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
    Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
    Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.
    Gutierrez-Camino A; Martin-Guerrero I; Garcia de Andoin N; Sastre A; Carbone Bañeres A; Astigarraga I; Navajas A; Garcia-Orad A
    PLoS One; 2017; 12(5):e0177421. PubMed ID: 28481918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
    Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
    Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.